The aim of this study was to assess the clinical efficacy and safety of NMES program applied in male soccer players (after ACL reconstruction) on the quadriceps muscle. The 80 participants (NMES = 40, control = 40) received an exercise program, including three sessions weekly. The individuals in NMES group additionally received neuromuscular electrical stimulation procedures on both right and left quadriceps (biphasic symmetric rectangular pulses, frequency of impulses: 2500 Hz, and train of pulses frequency: 50 Hz) three times daily (3 hours of break between treatments), 3 days a week, for one month. The tensometry, muscle circumference, and goniometry pendulum test (follow-up after 1 and 3 months) were applied. The results of this study show that NMES (in presented parameters in experiment) is useful for strengthening the quadriceps muscle in soccer athletes. There is an evidence of the benefit of the NMES in restoring quadriceps muscle mass and strength of soccer players. In our study the neuromuscular electrical stimulation appeared to be safe for biomechanics of knee joint. The pathological changes in knee function were not observed. This trial is registered with Australian and New Zealand Clinical Trials Registry ACTRN12613001168741.
Background. Interdisciplinary physical therapy together with pharmacological treatment constitute conservative treatment strategies related to low back pain (LBP). There is still a lack of high quality studies aimed at an objective evaluation of physiotherapeutic procedures according to their effectiveness in LBP.
SummaryIntroduction: The primary lymphedema and chronic venous insufficiency are important medical problems in women during menopause. Intermittent pneumatic compression has been accepted as a supplemental therapy for many years. However, due to the diversity of the clinical view of venous lymphedema and difficulties in the diagnosis, there is still no uniform and fully reliable treatment algorithm and international consensus.Aim of the study: To compare the efficacy of pneumatic compression of various pressure for the treatment of lower extremity venous lymphedema in menopausal patients.Material and methods: The study included 33 patients with chronic venous insufficiency and bilateral primary lymphedema of the lower limbs. Group A consisted of 10 patients aged from 46 to 56 years (mean age 51.2 years) who had used monthly therapy, treatments consisting of manual lymphatic drainage, multi-layer bandaging and intermittent pneumatic compression with a pressure of 120 mm Hg. Group B consisted of 10 patients aged from 45 to 58 years (mean age 53.3 years) who had identical basic treatment as group A, and intermittent pneumatic compression with a pressure of 60 mm Hg. Group C (control) consisted of 13 patients aged from 44 to 57 years (mean age 52.8 years) who were using only primary treatment without intermittent pneumatic compression.Results: It was found out that the greatest reduction in edema in patients undergoing compression settings with a pressure of 120 mm Hg. Comparison of the percentage reduction in edema showed a statistically significant advantage for group A to groups B and C, both for changes in the right (p = 0.01) and left limb (p = 0.01). Results in patients undergoing intermittent pneumatic compression with a lower pressure (60 mm Hg) were similar to those obtained in the control group.Conclusions: Intermittent pneumatic compression with a pressure of 120 mm Hg significantly helps to reduce the venous lymphedema in patients with menopause. It appears that the procedures with a pressure of 60 mm Hg are ineffective.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.